Effect of potentiated antibodies to cyclophosphamide on the development of tumors and effectiveness of cytostatic therapy under experimental conditions

E N Amosova; E P Zueva; T G Razina; S G Krylova; N V Shilova; O I Epstein

doi:10.1023/a:1024722528171

Effect of potentiated antibodies to cyclophosphamide on the development of tumors and effectiveness of cytostatic therapy under experimental conditions

Bull Exp Biol Med. 2003 Jan:135 Suppl 7:54-6. doi: 10.1023/a:1024722528171.

Authors

E N Amosova¹, E P Zueva, T G Razina, S G Krylova, N V Shilova, O I Epstein

Affiliation

¹ Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.

PMID: 12949650
DOI: 10.1023/a:1024722528171

Abstract

Antibodies to cyclophosphamide obtained by homeopathic potentiation and administered in ultralow doses exhibit no antiblastic activity and did not modulate the effectiveness of cyclophosphamide during antitumor therapy of animals with transplanted tumors (Lewis lung carcinoma and Ehrlich adenocarcinoma).

MeSH terms

Animals
Antibodies / immunology
Antibodies / therapeutic use*
Antineoplastic Agents, Alkylating / therapeutic use*
Carcinoma, Ehrlich Tumor / drug therapy*
Carcinoma, Lewis Lung / drug therapy*
Cyclophosphamide / immunology*
Cyclophosphamide / therapeutic use*
Cytostatic Agents / therapeutic use*
Dose-Response Relationship, Drug
Mice
Mice, Inbred C57BL
Neoplasms, Experimental / drug therapy

Substances

Antibodies
Antineoplastic Agents, Alkylating
Cytostatic Agents
Cyclophosphamide